Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: results from the RETRACT-B study. Oral Presentation. Proceeding/Conference:The Liver Meeting 2021 (AASLD 2021), 12-15 November 2021. Hepatology | 2021 | ||
Yeo, YHHo, HJYang, HITseng, TCKwak, M-SPark, YMFung, JYYButi, MRodriguez, MTreeprsertsuk, SPreda, CMUngtrakul, TCharatcharoenwithaya, PLi, XLe, MHWei, BZou, BLe, AKJeong, DChien, NKam, LHosaka, TRiveiro, MProca, DSuzuki, FKobayashi, MSriprayoon, TChong, YTanwandee, TYuen, RMFLee, H-SKao, J-HLok, AWu, C-YNguyen, MH | 2018 | ||
Viral and ALT kinetics after nucleos (t)ide analogue withdrawal among patients who remain off-therapy: results from a global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study). Poster Presentation (SAT400) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology | 2022 |